Caprico Biotechnologies

Caprico Biotechnologies is a privately held, revenue-generating biotech company serving the research and diagnostic sectors with a focus on antibody and protein reagents. The company leverages a core competency in custom antibody development, conjugation, and assay services, supported by ISO 13485:2016 and cGMP-compliant manufacturing. Its business model combines the sale of catalog products (e.g., fluorophore-conjugated antibodies, ASRs) with high-margin custom service contracts, positioning it as a flexible partner for academic, pharmaceutical, and diagnostic clients. Key strategic partnerships, such as with AAT Bioquest for novel fluorophores, enhance its technology portfolio.

Platform for custom monoclonal antibody design, development, and conjugation, featuring proprietary and partnered (AAT Bioquest) fluorophore technologies (iFluor, mFluor). Operations are supported by ISO 13485:2016 and cGMP-compliant manufacturing.

Competes with large, diversified life science tools companies (e.g., Thermo Fisher, BD Biosciences) and specialized antibody/reagent manufacturers. Differentiation is achieved through a strong custom services model, ISO/cGMP manufacturing for diagnostics, and partnerships for advanced fluorophore technology.